Antiviral treatment of severe non-influenza respiratory virus infection

Current Opinion in Infectious Diseases
Nathan J Brendish, Tristan W Clark

Abstract

Non-influenza respiratory virus infections are a frequent cause of severe acute respiratory infections, especially in infants, the elderly, and the immunocompromised. We review here the current treatment options for non-influenza respiratory viruses and promising candidate antiviral agents currently in development. Small molecule antiviral agents active against respiratory syncytial virus (RSV), such as ALS-8176 and GS-5806, show considerable promise in challenge studies and are undergoing late-phase clinical trials in hospitalised adults and children. Monoclonal antibodies (mAbs) active against non-influenza respiratory viruses are broadly at a preclinical stage. Broad-spectrum antivirals, such as favipiravir and nitrazoxanide, have potential utility in treating illness caused by non-influenza respiratory viruses but further definitive clinical trials are needed. Severe non-influenza respiratory virus infection is common and current treatment is largely supportive. Ribavirin is used in immunocompromised patients but its use is limited by toxicity and the evidence for its efficacy is weak. Effective antiviral treatment for RSV may shortly become available, pending the results of ongoing clinical trials. For other non-influenza ...Continue Reading

References

Jun 14, 2002·The Lancet Infectious Diseases·Kath Senior
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick G HaydenUNKNOWN Pleconaril Respiratory Infection Study Group
Mar 23, 2005·The Journal of Experimental Medicine·Peter A B WarkDonna E Davies
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·John DeVincenzoAkshay Vaishnaw
Sep 21, 2010·American Journal of Respiratory and Critical Care Medicine·Martin R ZamoraAllan R Glanville
Oct 4, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Diana F FlorescuCharles van der Horst
Sep 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alpana WaghmareMichael Boeckh
Oct 3, 2013·Antiviral Research·Yousuke FurutaDale L Barnard
Dec 21, 2013·The Pediatric Infectious Disease Journal·Octavio RamiloUNKNOWN Motavizumab Study Group
Apr 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Xian-Chun TangWayne A Marasco
May 24, 2014·The Lancet Infectious Diseases·Jason HaffizullaUNKNOWN US Nitazoxanide Influenza Clinical Study Group
Jun 18, 2014·American Journal of Respiratory and Critical Care Medicine·Ratko DjukanovićUNKNOWN INTERCIA Study Group
Aug 12, 2014·Antiviral Research·Jean-François Rossignol
Aug 21, 2014·The New England Journal of Medicine·John P DeVincenzoJason W Chien
Jul 15, 2015·The New England Journal of Medicine·Seema JainUNKNOWN CDC EPIC Study Team
Jul 29, 2015·The Journal of Infection·Nathan J BrendishTristan W Clark
Oct 11, 2015·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jens GottliebAllan R Glanville
Nov 19, 2015·The New England Journal of Medicine·John P DeVincenzoJohn Fry
Apr 21, 2016·Journal of Infection and Public Health·Jean-François Rossignol
Aug 18, 2016·Emerging Infectious Diseases·Yaseen M ArabiMashail Alahmadi
Sep 30, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marie von Lilienfeld-ToalKarin Mayer
Jan 6, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Ann R FalseyEdward E Walsh
Jan 9, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael S GrimleyVinod K Prasad
Jul 1, 2017·Current Opinion in Infectious Diseases·Yeon Joo LeeGenovefa A Papanicolaou

❮ Previous
Next ❯

Citations

Oct 16, 2018·Current Opinion in Infectious Diseases·Marjorie V BatistaRoy F Chemaly
Jan 21, 2020·Praxis der Kinderpsychologie und Kinderpsychiatrie·Alisa Manske, Stefanie J Schmidt
Jul 6, 2019·Frontiers in Cellular and Infection Microbiology·Susanna EspositoNicola Principi
Feb 10, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hang YinSong Wang
Jun 3, 2021·Pharmaceutics·Mehwish JabeenClaire Monge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

Expert Review of Respiratory Medicine
Patricia A Jorquera, Ralph A Tripp
The Cochrane Database of Systematic Reviews
Adrienne Randolph, E E Wang
© 2022 Meta ULC. All rights reserved